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Multiple Gln/Asn-Rich Prion Domains Confer
Susceptibility to Induction
of the Yeast [PSI] Prion
Genomic searches for Gln/Asn-rich domains similar
to the Sup35p prion domain have led to the identification
of prion domains in two previously uncharacterized pro-
teins, New1p and Rnq1p (Michelitsch and Weissman,
2000; Santoso et al., 2000; Sondheimer and Lindquist,
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2000). When the Gln/Asn-rich regions of these proteins513 Parnassus Avenue
were fused to the C-terminal translational terminationSan Francisco, California 94143
domain of Sup35p, the resulting fusion proteins could
reversibly aggregate to form stably heritable prion
states, termed [NU] and [RPS], which emulated theSummary
[PSI] nonsense suppression phenotype. Full-length
Rnq1p exists predominantly in an aggregated form in aThe yeast prion [PSI] results from self-propagating
number of laboratory strains, but this prion state causesaggregates of Sup35p. De novo formation of [PSI]
no apparent change in phenotype (Sondheimer and Lind-requires an additional non-Mendelian trait, thought to
quist, 2000).result from a prion form of one or more unknown pro-
Glutamine-rich aggregates are also associated withteins. We find that the Gln/Asn-rich prion domains of
human disease (Perutz, 1999). Several heritable neuro-two proteins, New1p and Rnq1p, can control suscepti-
degenerative diseases including Huntington’s Diseasebility to [PSI] induction as well as enhance aggrega-
and a variety of spinocerebellar ataxias are caused bytion of a human glutamine expansion disease protein.
expansion of CAG codons leading to the production of[PSI] inducibility results from gain-of-function prop-
proteins with long polyglutamine (polyGln) tracts. In vivo,erties of New1p and Rnq1p aggregates rather than
these aberrant proteins form inclusions in affected neu-from inactivation of the normal proteins. These studies
rons that correlate with neurodegeneration. Further-suggest a molecular basis for the epigenetic control
more, expanded polyGln tracts within the Huntingon’sof [PSI] inducibility and may reveal a broader role for
Disease protein cause it to form self-seeding amyloidthis phenomenon in the physiology of protein aggre-
fibrils in vitro (Scherzinger et al., 1999). The structuralgation.
basis of Gln/Asn-rich aggregation is thought to involve
formation of “polar zippers” in which the  sheets areIntroduction
stabilized by a network of hydrogen bonds involving
glutamine and aspargine sidechains (Perutz et al., 1994).Infectious, self-propagating protein aggregates (prions)
Although Gln/Asn-rich domains have an inherent pro-constitute a conformational mechanism of inheritance.
pensity to form amyloid aggregates in vitro, cellular fac-Originally described as mammalian pathogens (Prusi-
tors strongly modulate the formation, propagation, andner, 1998), prions have recently been shown to underlie
toxicity of such aggregates in vivo. Notably, the propa-a number of non-Mendelian traits in fungi (Wickner et
gation of [PSI] in yeast as well as of polyGln aggregatesal., 1999). While the prion proteins responsible for these
in yeast, worms, and mammalian cells can be modulatedvarious phenomena are otherwise unrelated, a common
by Hsp104p, a yeast chaperone involved in thermal tol-feature of prion conversion is the formation of -sheet-
erance and disaggregation of misfolded proteins (Cher-rich, amyloid aggegrates. In mammals, prions cause
noff et al., 1995; Lindquist et al., 1995; Carmichael etneurodegeneration and death, but in Saccharomyces
al., 2000; Krobitsch and Lindquist, 2000; Satyal et al.,
cerevisiae, they allow the epigenetic control of protein
2000). Elevated levels of Hsp70 chaperones can also
activity, which can in certain circumstances prove adap-
ameliorate the effect of polyGln protein aggregation and
tive (Eaglestone et al., 1999; True and Lindquist, 2000). can influence the efficiency of [PSI] propagation in
The best-characterized yeast prions are [URE3] and yeast (Chernoff et al., 1999; Warrick et al., 1999; Mu-
[PSI], which result from the aggregation of the nitrogen chowski et al., 2000).
catabolism repressor Ure2p and the translation termina- In addition to genome-encoded factors such as chap-
tion factor Sup35p, respectively. Incorporation of these erones, a remarkable additional element, which is itself
proteins into prion aggregates diminishes their normal inherited in a non-Mendelian manner, regulates the de
activity, emulating Mendelian loss-of-function muta- novo appearance of [PSI] (Derkatch et al., 1997, 2000).
tions; for example, [PSI] causes the suppression of In yeast strains possessing the [PSI] inducibility factor
certain nonsense mutations. The prion properties of (termed [PIN]), transient overexpression of the Sup35p
Ure2p and Sup35p depend on glutamine- and aspara- prion domain leads to the appearance of [PSI] at a high
gine-rich (Gln/Asn-rich) domains at the amino terminus frequency. In contrast, strains lacking the [PIN] factor
of each protein (Serio and Lindquist, 1999; Wickner et (referred to as [pin]) do not convert to [PSI] upon
al., 1999). These prion domains are dispensable for the Sup35p overexpression. Propagation of [PIN] does not
normal functions of their proteins and are modular, con- depend on Sup35p and, like known yeast prions, [PIN]
ferring the ability to aggregate when transferred to other is inherited in a cytoplasmic manner, requires the pres-
proteins (Wickner et al., 2000). ence of Hsp104p, and can be eliminated by treatment
of cells with guanidine. Despite these arguments for a
prion basis for [PIN], the specific prion-forming protein1 Correspondence: lxoshe@itsa.ucsf.edu
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Figure 1. New1p and Rnq1p Prion Domains
Facilitate Conversion to [PSI]
(A) New-GFP overexpression circumvents the
requirement for [PIN] in [PSI] induction. The
indicated proteins were overexpressed in a
[psi] [pin] strain, and the frequency of con-
version to ADE was determined by plating
equal quantities of cells onto media with or
without adenine. For comparison, a [psi]
[PIN] control expressing Sup-GFP alone is
shown. In these and subsequent prion induc-
tion experiments, each column represents
the sum of 2–5 independent experiments in
which 200–400 colonies were counted.
(B) Reversibility of ADE in New1p-mediated
convertants. ADE convertants obtained by
dual overexpression of Sup-GFP and New-
GFP (New1p convertant) are shown before
and after treatment with 5 mM guanidine hy-
drochloride (GuHCl) along with [PSI] and
[psi] controls.
(C) Biochemical evidence that New1p-medi-
ated convertants are [PSI]. Extracts from the
indicated strains were subjected to ultracen-
trifugation; the presence of Sup35p in the su-
pernatant (S) or pellet (P) was determined by
immunoblotting after SDS-PAGE.
(D) Effect of other Gln/Asn-rich domains on
[PSI] induction. Residues 153–415 of Rnq1p,
1–295 of Sup35pCA, and 1–240 of Pan1p were
fused to GFP and tested for [PSI] induction
when overexpressed in a [psi] [pin] strain
together with Sup-GFP. Sup-GFP alone in a
[psi] [PIN] strain is shown at left. In all
strains, overexpression of these proteins
alone did not induce [PSI] (data not shown).
The lower efficiency of [PSI] induction by
Rnq-GFP compared to New-GFP is likely due
to the lower propensity of Rnq-GFP to aggre-
gate de novo in [pin] strains.
(E) Scheme for ascertaining the presence of
[PIN] in New1p- and Rnq1p-mediated [PSI] convertants. The [PSI] factor is eliminated by overexpression of Hsp104p, then Sup-GFP is
transiently overexpressed. If the strain is [PIN], [PSI] should reappear (bottom left), whereas in [pin] strains, Sup-GFP overexpression
should not induce [PSI] (bottom right).
(F) New1p-mediated [PSI] convertants are [pin]. We used the scheme in (E) to test for the presence of [PIN] in a New1p-mediated convertant.
For comparison, conversion rates in [pin] and [PIN] strains are shown.
or proteins associated with the [PIN] state have re- and the green fluorescent protein, termed New-GFP and
Sup-GFP, respectively. In contrast to Sup-GFP, whichmained mysterious.
does not aggregate in [pin] strains, overexpressedWe thus have two new prion proteins with unknown
New-GFP formed visible aggregates (see Figure 5D).functions (New1p and Rnq1p) and an epigenetic prion-
We assayed for [PSI] induction by using strains withlike phenomenon ([PIN]) without a known protein. Here,
a nonsense mutation in the ADE1 gene (ade1-14) thatwe establish that prion forms of both New1p and Rnq1p
permits growth on medium lacking adenine (ade) ascan promote [PSI] formation. The identification of
a result of [PSI]-mediated nonsense suppression.[PSI]-inducing prions has allowed us to examine the
We found that overexpression of New-GFP circum-mechanism of prion formation and to uncover a broader
vented the requirement for [PIN] in [PSI] induction.role for prions in modulating polyGln aggregation.
As expected, overexpression of New-GFP or Sup-GFP
alone did not induce [PSI] in [pin] strains (conversion
Results frequencies 106, Figure 1A). However, overexpres-
sion of both Sup-GFP and New-GFP in a [pin] strain
Overexpression of Non-Sup35p Prion Domains caused the appearance of adenine prototrophic (ADE)
Confers [PSI] Susceptibility colonies at a frequency (6  102) comparable to that
To test whether newly identified prions could, like [PIN], occurring after overexpression of Sup-GFP alone in a
act as [PSI]-promoting factors, we examined the effect [PIN] strain. We obtained similar results using full-
of New1p aggregates on [PSI] induction. For these length New1p in place of New-GFP (data not shown).
studies, we transiently overexpressed fusion proteins Several observations argued that these ADE con-
composed of either the New1p prion domain (residues vertants resulted from the de novo appearance of the
[PSI] prion. First, they formed visible colonies after1–153) or the Sup35p prion domain (residues 1–253)
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Table 1. Genetic Analysis of New1- and Rnq1-Mediated [PSI] Induction
Overexpressed Protein Conversion to [PSI]
Sup-GFP New-GFP Rnq-GFP wild-type Dnew1† Drnq1
√   
√   
[pin] √   
√ √   
√ √   
[PIN] √   —*
[psi] strains of a NEW1 RNQ1 (wild-type), Dnew1 or Drnq1 background over expressing the indicated GFP fusion proteins were assayed for
conversion to [PSI] in the presence or absence of [PIN] by growth onade. — indicates no conversion to [PSI], indicates1% conversion
and  represents 10% conversion. All Dnew1 experiments (†) showed delayed manifestation of [PSI]; colonies appeared on ade after
14 days, instead of the 5 days seen with wild-type strains.
* indicates permanent loss of the [PIN] factor; unlike their wild type sister spores, Drnq1 haploids derived from a [PIN] Drnq1/ diploid
failed to manifest [PIN] as assayed by Sup-GFP aggregation and [PSI] induction and did not transmit [PIN] in subsequent back-crosses
against RNQ1 [pin] strains.
approximately 5 days on ade and displayed variable of Sup-GFP to induce [PSI]. We found that [PSI] induc-
ibility arose from novel, gain-of-function properties ofdegrees of strength and stability of the ADE trait, fea-
tures typical of fresh [PSI] inductants (Derkatch et al., New-GFP and Rnq-GFP aggregates. Neither deletion of
NEW1 nor RNQ1 rendered [pin] yeast susceptible to1996). Additionally, the ADE property of these con-
vertants could be abolished by treatment with guanidine [PSI] induction by Sup-GFP alone (Table 1). Moreover,
[PSI] induction by dual overexpression of Sup-GFP(Tuite et al., 1981), which cures all known yeast prions
(Figure 1B). Finally, in extracts prepared from a New1p- together with New-GFP or Rnq-GFP still occurred in
these deletion strains. Thus, New1p- and Rnq1p-medi-converted strain, Sup35p fractionated entirely to the
pellet following ultracentrifugation (Figure 1C), indicat- ated [PSI] induction does not arise from loss of the
activity of their corresponding full-length proteins. Ining that the ADE property of these strains arose from
prion formation by Sup35p (Patino et al., 1996; Paushkin contrast, deletion of RNQ1 prevented the manifestation
and propagation of the classical [PIN] factor, a findinget al., 1996).
We tested whether other Gln/Asn-rich proteins could consistent with the identification of Rnq1p as the protein
determinant of [PIN] (Derkatch et. al, 2001 [this issuepromote [PSI] induction by overexpressing GFP fu-
sions of the prion domains of two other known prion- of Cell]). In new1 strains, there was a significant delay
in the onset of the [PSI] phenotype regardless offorming proteins, Rnq1p and Candida albicans Sup35p
(Sup35pCA) (Santoso et al., 2000; Sondheimer and Lind- whether [PSI] induction was promoted by New-GFP,
Rnq-GFP, or [PIN] (Table 1 and data not shown). Oncequist, 2000), as well as the Gln/Asn-rich portion of
Pan1p. We saw varying levels of GFP aggregation in converted, [PSI] new1 strains grew at a normal rate,
suggesting that the chromosomally-encoded New1p as-[pin] strains expressing each of these proteins alone.
However, only the Rnq-GFP fusion promoted [PSI] in- sists in the induction but not propagation of [PSI].
duction, although at a lower frequency (5  103) than
did New-GFP (Figure 1D). Thus, only a subset of Gln/ Aggregation of New1p NYN Repeats Is Needed
for [PSI] InductionAsn-rich aggregates facilitate [PSI] induction.
The induction of [PSI] by dual overexpression of Sup- We next constructed a panel of truncated New1p-GFP
fusions in order to investigate the relationship betweenGFP and New-GFP could result from the conversion of
the cells from [pin] to [PIN], which would then permit the aggregation of New1p and its ability to promote
[PSI] induction. The prion domain of New1p contains[PSI] induction by excess Sup-GFP (Derkatch et al.,
2000). However, when we eliminated the [PSI] factor a particularly Gln/Asn-rich region between residues 50
and 100. Notably, residues 62-70 (QQGGYQSYN) resem-from the New-GFP- or Rnq-GFP-mediated inductants
using Hsp104p overexpression, a treatment which does ble an oligopeptide repeat found in Sup35p (PQGGYQ-
QYN) that influences the stability and severity of [PSI]not cure [PIN] (Derkatch et al., 1997), the resulting [psi]
strains proved refractory to reinduction of [PSI] by ov- (Liu and Lindquist, 1999), while residues 71–100 of
New1p contain the repeating tripeptide sequence NYNerexpression of Sup-GFP alone (Figures 1E and 1F; data
not shown), indicating that these strains had remained (Figure 2A).
We found that an intact NYN-rich region is essential[pin]. Thus, New1p- and Rnq1p-mediated conversion
from [psi] to [PSI] occurred without conversion to for both New1p aggregation and its ability to promote
[PSI] induction (Figure 2B), whereas other portions of[PIN].
the New1p prion domain proved unnecessary for either
effect. The C-terminal GFP domain was not required for[PSI] Susceptibility Does Not Arise
from Inactivation of Chromosomally [PSI] inducibility, as overexpression of an EE epitope-
tagged version of the NYN region also promoted [PSI]Encoded New1p and Rnq1p Proteins
To determine the roles of full-length New1p and Rnq1p formation. Replacement of the first or third asparagine
pairs of the NYN motif with large, positively chargedin [PSI] induction, we deleted the corresponding genes
and tested the effect of these mutations on the ability residues (arginines) decreased both aggregation and
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for continuous New-GFP overexpression, we replaced
the chromosomal copy of SUP35 with an episomal gene
encoding a fusion of the New1p prion domain and the
essential translation termination domain of Sup35p. In
the resulting strains, this protein (termed New-EF) could
be interconverted from a soluble [nu] form to the self-
propagating aggregated state, [NU] (Santoso et al.,
2000). In [NU] strains, the majority of chromosomally
encoded New1p protein is also aggregated (data not
shown). As with [PSI], the [NU] state could be moni-
tored phenotypically by nonsense suppression of ade1-
14, resulting in adenine prototrophy.
We first established the prion nature of New-EF aggre-
gates responsible for [NU]. As with other yeast prions,
transient treatment of [NU] cells with guanidine caused
efficient reversion to the [nu] state (Figure 3A). Similarly,
we were unable to obtain [NU] isolates in strains lacking
Hsp104p, which is thought to be the target of guanidine
(Jung and Masison, 2001) (data not shown). New-EF
protein is required for the propagation of [NU], as tran-
sient loss of the New-EF-expressing plasmid caused
reversion to [nu] (Figure 3B). Finally, [NU] can be trans-
mitted in an “infectious” manner through cytoplasmic
transfer (cytoduction) from [NU] cells to karyogamy-
defective [nu] cells (Figure 3C). Whereas [NU] donors
efficiently transferred adenine prototrophy to [nu] re-
cipients, no ADE colonies were obtained when [nu]
Figure 2. Mutational Analysis Reveals a Relationship between donors were used. Combined with previously published
New1p Aggregation and [PSI] Induction
data (Santoso et al., 2000), these results confirmed that
(A) A schematic diagram of the New1p prion domain (residues 1–153). [NU] results from an infectious, reversible, conforma-
The oligopeptide region similar to Sup35p (QQGGYQSYN, residues
tional isoform (i.e., prion) of the New-EF protein.62–70, gray) and the NYN repeat motif (residues 70–100, black) are
We next created a panel of strains that harbored one,indicated.
both, or neither of the [PIN] or [NU] prions and used(B) NYN motif of New1p confers both aggregation and [PSI] induc-
ibility. Fusions between the indicated regions of New1p and GFP fluorescence microscopy to monitor the formation of
were assayed for focus formation (visualized by fluorescent micros- Sup-GFP aggregates, which appeared as both foci and
copy) when overexpressed alone, as well as the ability to facilitate “ribbons” (Figure 4A). Although it is unknown whether
[PSI] induction when overexpressed along with Sup-GFP. The
these structures are active [PSI] seeds, their formationNew70-100-EE construct was approximately 10 times less effective
depends on the induction or presence of [PSI] and thusthan the New-GFP construct at inducing [PSI] in conjunction with
serves as an indicator of [PSI] susceptibility (Patino etSup-GFP, possibly due to poor expression.
(C) Disruption of the NYN motif affects aggregation and [PSI] induc- al., 1996; Zhou et al., 2001).
ibility. Pairs of arginines (denoted RR) were introduced in place of We found that [NU] conferred susceptibility to [PSI]
asparagine pairs at the indicated positions in the NYN tract of induction in a manner that was comparable to but inde-
New170-100-GFP. The percentage of cells containing visible GFP inclu- pendent of [PIN]. [NU] alone promoted the appear-
sions and cells converted to [PSI] are shown.
ance of Sup-GFP foci at an efficiency somewhat higher
than [PIN] alone, and in combination, [NU] and [PIN]
resulted in a further increase in the formation of foci
conversion to [PSI] (Figure 2C). Compared to an unmu-
(Figure 4B). By contrast, no Sup-GFP aggregates were
tated control, the distal arginine mutations diminished seen in cells lacking both prion elements, including
both the fraction of cells with aggregates and the rate of [NU] [pin] strains that spontaneously reverted to [nu]
[PSI] induction roughly 6-fold; introduction of arginine [pin] (Figure 4B and data not shown). We directly dem-
residues near the center of the NYN motif completely onstrated the presence of prion seeds in cells with such
abolished both the aggregation and [PSI]-promoting Sup-GFP aggregates by using them to seed the conver-
properties of New1p. These data argue that susceptibil- sion of full-length Sup35p to a [PSI] state. We first
ity to [PSI] induction arises from aggregation of New1p accumulated Sup-GFP aggregates in sup35 strains,
via its NYN repeat motif. then exposed these aggregates to full-length Sup35p
through mating with a [psi] [pin] strain with an intact
The [NU] Prion Confers Susceptibility SUP35 gene (depicted in Figure 4C); the resulting dip-
to [PSI] Induction loids were assayed for conversion to [PSI]. Only donor
The preceding experiments linked [PSI] inducibility to strains with visible Sup-GFP aggregates prior to mating
the presence of New-GFP aggregates produced by over- (i.e, strains with either the [NU] or [PIN] prions) yielded
expression. We asked whether low levels of a constitu- [PSI] diploid colonies (Figure 4D). Taken together,
tively aggregated form of the New1p prion domain could these findings establish that prion-facilitated [PSI] in-
also confer [PSI] inducibility. To generate pure popula- ducibility can arise from the presence of multiple inde-
pendent prions.tions of cells containing such aggregates without a need
Prion-Based Regulation of Protein Aggregation
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Figure 3. [NU] Is a Prion Form of New-EF
(A) [NU] is eliminated by guanidine treat-
ment. Shown are spotted cultures of [nu]
and [NU] strains and the [NU] strain after
transient growth (approximately 20 genera-
tions) in the presence of guanidine. The
strains shown here and in subsequent panels
are [PIN], but similar results were obtained
with [pin] derivatives.
(B) Propagation of [NU] requires the continu-
ous expression of the New-EF protein. [NU]
strains bearing an episomal copy of New-EF
were transformed with a plasmid encoding
Sup35p and were allowed to lose the New-
EF plasmid. These isolates were then retrans-
formed with the New-EF plasmid and were
allowed to lose the SUP35 plasmid. When
tested for ade1-14 nonsense suppression
after this plasmid “shuffle,” the resulting
strains had lost the [NU] trait.
(C) [NU] is efficiently transmitted by cyto-
plasmic transfer (cytoduction). Cytoductants
from [nu] or [NU] donor strains to a karyo-
gamy-deficient [nu] recipient are shown
growing on media with low or no adenine
(top). Cytoductable adenine prototrophy was
abolished by growth on medium with guani-
dine (bottom), confirming its prion basis.
Shown are streaks from nonclonal cytoduc-
tant patches; when individual cytoductant
colonies were scored for [NU], 17 of 17 colo-
nies obtained using a [NU] donor had be-
come [NU], while 17 of 17 colonies from
[nu] donor remained [nu]. For comparison,
the [NU] and [nu] donor stains are also
shown.
New1p Aggregates Do Not Appear to Seed did not colocalize (Figure 5F). Thus, the presence of New-
CFP permitted the ordinarily soluble Sup-YFP to aggre-Sup35p Polymerization
New1p or Rnq1p prions could promote [PSI] induction gate, but not into the same inclusions as New-CFP.
by providing a nucleating seed into which Sup35p could
become incorporated. However, several experiments
designed to detect such cross-seeding yielded negative The Role of Chaperones in [PSI] Induction
Another possible basis for New1p-mediated [PSI] in-results. First, New-GFP overexpression did not by itself
stimulate [PSI] induction, even in an already suscepti- duction might involve changes in the activities of chap-
erones that modulate [PSI]. The presence of aggre-ble [PIN] strain (Figures 1A and 5A). Conversely,
Sup35p aggregates produced by overexpressing Sup- gated New1p could in principle elevate Hsp104p
activity, which has been suggested to stimulate the fold-GFP in a [PIN] strain did not increase the rate of appear-
ance of [NU] (Figure 5B). Additionally, overexpression ing of the [PSI] form of Sup35p. However, we found
that New-CFP promoted Sup-YFP aggregation even inof Sup35p did not induce [PIN] (Derkatch et al., 1997).
Finally, the presence of purified recombinant New1p the absence of Hsp104p. In a strain lacking Hsp104p,
Sup-YFP displayed diffuse localization when overex-prion domain did not affect the kinetics of Sup35p prion
domain polymerization in vitro (data not shown). pressed alone (Figure 6A), while New-CFP formed ag-
gregates (Figure 6B) similar to those seen in wild-typeTo test directly for cross-interaction between Sup35p
and New1p prion domains in vivo, we examined the controls (Figure 5D). As in wild-type cells, the presence
of New-CFP permitted Sup-YFP to aggregate (Figurelocalization of these proteins in the same cells using
two-color fluorescence microscopy. A fusion of the 6C). Overexpression of chaperones also did not prevent
New-GFP from stimulating [PSI] induction. We ex-Sup35p prion domain with yellow fluorescent protein
(Sup-YFP) displayed diffuse cytoplasmic localization pressed New-GFP and Sup-GFP in a strain bearing a
high-copy HSP104 plasmid previously shown to curewhen overexpressed alone in a [pin] strain (Figure 5C);
in contrast, a New1p prion domain–cyan fluorescent [PSI], but this did not have a substantial effect on the
ability of New-GFP to promote [PSI] induction (Figureprotein fusion (New-CFP) formed aggregates when ov-
erexpressed alone in the same strain (Figure 5D). When 6D). We performed similar experiments with high-copy
plasmids encoding Ssa1p and Ssb1p, two Hsp70 pro-these proteins were overexpressed together, 2%–5% of
the cells displayed aggregates of Sup-YFP (Figure 5E) teins known to affect [PSI] formation (Chernoff et al.,
1999; Newnam et al., 1999), and obtained similar resultsas well as of New-CFP, but these two types of inclusions
Cell
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Figure 4. [NU] Confers Susceptibility to [PSI] Induction
(A) Sup-GFP forms aggregates in [PIN] or [NU] cells. Sup-GFP was expressed from a copper-inducible, high-copy plasmid in strains
harboring neither, one, or both of the [PIN] and [NU] prions, as indicated. After 48 hr of expression, foci and ribbons of fluorescence were
visible in cells harboring at least one prion. In this and subsequent fluorescence localization experiments (all of which were performed under
similar conditions), 50% of cells had little or no detectable fluorescence; nonfluorescent cells were nonetheless included in all quantitative
analyses.
(B) Frequency of Sup-GFP focus formation in cells treated as described in (A).
(C) Scheme for testing the ability of preformed Sup-GFP aggregates to seed prion conversion of full-length Sup35p. Chromosomal SUP35
(blue) was disrupted, allowing [NU] to be monitored by inactivation of the New-EF protein (green). Aggregates of Sup-GFP (orange) were
accumulated by copper-induced overexpression from the pCup1-SUPGFP plasmid (top left). The cells were then mated with a [psi] [pin]
strain expressing full-length Sup35p (middle). The [PSI] state of the resulting diploid was assayed by growth on ade. The appearance of
[PSI] indicated that Sup-GFP aggregates had seeded the prion conversion of full-length Sup35p (bottom). Similar experiments were performed
starting with cells lacking [PSI]-promoting prions, with [PIN] alone or with both [NU] and [PIN]. In all cases, diploids were plated on
medium that allowed the loss of the Sup-GFP- and New-EF-encoding plasmids.
(D) Demonstration that Sup-GFP aggregates formed as a result of the presence of [NU] and [PIN] can seed [PSI] induction. Cells with
neither, one, or both of the [PIN] and [NU] prions were treated as described in (C). The top panel (low ade) shows the growth of all diploids,
while the bottom panel (no ade) shows the growth of [PSI] diploids only. Note lack of growth in top left quadrant of bottom panel.
(data not shown). These observations indicate that the more, they suggest that Hsp104p, which is absolutely
required for the propagation of [PSI], is not needed foreffect of New1p aggregates is not mitigated by altering
levels of chaperones known to modulate [PSI]. Further- the de novo formation of Sup35p aggregates.
Prion-Based Regulation of Protein Aggregation
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Figure 5. Lack of Cross-Interaction between
New-GFP and Sup-GFP
(A) New-GFP aggregates do not induce
[PSI]. The indicated GFP fusion proteins
were overexpressed in a [psi] [PIN] strain
and the frequency of conversion to [PSI] was
determined as in Figure 1A.
(B) Sup-GFP aggregates do not induce [NU].
The indicated GFP fusion proteins were over-
expressed in a [nu] [PIN] strain. Conversion
to [NU] was monitored by nonsense sup-
pression resulting from aggregation of New-
EF protein. Note that the spontaneous fre-
quency of appearance of [NU] is 103,
significantly higher than that of [PSI].
(C) Sup-YFP overexpressed alone in a [psi]
[pin] strain displays diffuse localization. In
these and subsequent micrographs, the prion
status, expressed proteins, and the fluores-
cent light channel are indicated.
(D) New-CFP forms aggregates when overex-
pressed in [psi] [pin] strains. The majority of
cells with visible fluorescence had inclusions,
as shown here.
(E) Sup-YFP forms filamentous aggregates in
a subset of cells when overexpressed to-
gether with New-CFP in a [psi] [pin] strain.
(F) New-CFP and Sup-YFP aggregates do not
colocalize. A field view with yellow, cyan, and
merged channels is shown at top, while the
bottom row shows a magnified view from a
separate experiment. In all cells with Sup-
YFP inclusions, New-CFP inclusions were
also observed. Lack of colocalization was
confirmed by 3D reconstruction of wide-field
microscopic images (O. Weiner and L.Z.O.,
data not shown).
Note: higher quality versions of this and other
figures are available electronically at http://
www.ucsf.edu/jswlab/downloads
[PSI] Inducibility Factors Promote tained similar results with a MJD protein-GFP fusion
containing 82 glutamines (data not shown). BiochemicalpolyGln Aggregation in Yeast
Finally, we asked whether the presence of [PSI]-pro- analysis confirmed that the [PIN] element promoted the
aggregation of Q62-GFP, as this protein was depleted bymoting prions affected the aggregation of Gln/Asn-rich
proteins other than Sup35p. We constructed GFP fu- ultracentrifugation from the supernatant of [PIN] but
not [pin] extracts (Figure 7B). Like [PIN], [NU] stimu-sions of normal and glutamine-expanded variants of a
fragment of the spinocerebellar ataxia type 3/Machado- lated the appearance of multiple fluorescent foci of
Q62-GFP (Figures 7C and 7D). However, [PSI] did notJoseph Disease (MJD) protein (Ikeda et al., 1996) and
overexpressed them in [pin] and [PIN] yeast. As ex- promote the formation of Q62-GFP foci (Figure 7C). To-
gether, these observations reveal a role for [PSI]-pro-pected, fusions with 22 glutamines (Q22-GFP) did not
aggregate in either strain. In contrast, a fusion con- moting prions in the general regulation of protein aggre-
gation and suggest a common mechanism for the initiationtaining a pathogenic number of glutamines (Q62-GFP)
formed visible foci, but the number and nature of these of Sup35p and polyGln disease protein aggregates.
aggregates was greatly altered by the presence of [PIN]
(Figures 7A–7C). In strains in which [PIN] had been Discussion
eliminated by guanidine treatment or deletion of
HSP104, Q62-GFP fluorescence was predominantly dif- Susceptibility to induction of the yeast [PSI] prion has
previously been shown to require a non-Mendelian ele-fuse, with some cells (6%) exhibiting a single large
inclusion (Figure 7A top right); cells containing multiple ment, [PIN], which itself propagates in a prion-like man-
ner (Derkatch et al., 1997, 2000). We have investigatedfoci were very rare (1%). However, in a [PIN] strain,
there were few cells with bright diffuse fluorescence; the role of two Gln/Asn-rich prion domains, those of
New1p and Rnq1p, in the process of [PSI] induction.cells with visible aggregates were more abundant
(28%) and most of these cells (18% of total) exhibited Our studies reveal that the prion forms of these proteins
control not only susceptibility to [PSI] formation butmultiple minute foci (Figure 7A bottom right). We ob-
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Figure 6. Altered Hsp104p Levels Do Not Af-
fect New1-Mediated Sup35p Aggregation or
[PSI] Induction
(A) Examples of the diffuse localization of
Sup-YFP observed in a hsp104 strain in the
absence of New-CFP overexpression.
(B) Examples of New-CFP aggregates in a
hsp104 strain.
(C) New-CFP-mediated aggregation of Sup-
YFP does not require Hsp104p. A [psi] [pin]
hsp104 strain overexpressing both Sup-
YFP and New-CFP displayed Sup-YFP inclu-
sions at a frequency (2%) similar to that
in [psi] [pin] cells with intact HSP104 (see
Figure 5E).
(D) Hsp104p overexpression does not affect
New1p-mediated [PSI] induction. [psi]
[pin] strains with or without a high-copy
HSP104 plasmid were plated ontoade after
overexpression of the indicated GFP fusion
proteins. When these strains were plated
ontoade while still selecting for the HSP104
plasmid, no ADE colonies were observed,
confirming that overexpressed HSP104 could
prevent [PSI] propagation (data not shown).
also enhance the aggregation of a fragment of a human of action by the prion forms of New-EF ([NU]) and
Rnq1p ([PIN]). Both prions render the cell susceptibledisease protein (MJD) containing a pathogenic number
of glutamine repeats. Additionally, we have described to [PSI] induction and enhance polyGln aggregation.
Furthermore, [PSI] susceptibility arising from eithera novel mode of yeast prion action that, as with the
mammalian prions, arises from gain-of-function proper- prion is partially compromised by deletion of the chro-
mosomal NEW1 gene. Finally, Sup-GFP aggregates gen-ties of protein aggregates rather than from the inactiva-
tion of the normal protein (Prusiner, 1998; Wickner et erated by virtue of [NU] and [PIN] are microscopically
indistinguishable and lead to a similar range of [PSI]al., 1999).
We have established that while susceptibility to [PSI] prion “strains” (Derkatch et al., 1996).
induction can be conferred by at least two yeast prion
domains, it is not an obligatory consequence of the A Saturable Antiaggregation System?
How do aggregates of New1p or Rnq1p make cells vul-accumulation of intracellular Gln/Asn-rich aggregates.
[PSI] inducibility is widespread among laboratory yeast nerable to [PSI] induction? Our findings exclude several
models. First, [PSI] induction does not occur as a resultstrains (L.Z.O. and J.S.W., unpublished data), as is the
presence of Rnq1p aggregates (Sondheimer and Lind- of the de novo appearance of the [PIN] factor. Second,
[PSI] induction does not arise through loss of functionalquist, 2000); indeed, an accompanying paper demon-
strates that the prion form of Rnq1p is responsible for New1p or Rnq1p; deletion of these genes did not confer
[PSI] inducibility. Third, New1p-mediated [PSI] sus-the classical [PIN] state (Derkatch et al., 2001 [this
issue of Cell]). Given the large number of other potential ceptibility is not solely caused by changes in Hsp104p
activity, as neither loss nor overexpression of Hsp104pprions in the yeast genome (Michelitsch and Weissman,
2000), it seems likely that additional, as-yet-undiscov- modulated this phenomenon.
[PSI] susceptibility could arise from cross-seedingered prions will also confer susceptibility to [PSI] in-
duction. between aggregates of Sup35p and those of New1p and
Rnq1p prion domains. However, several observationsSeveral observations suggest a common mechanism
Prion-Based Regulation of Protein Aggregation
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Figure 7. [PIN] and [NU] Promote Aggregation of the polyGln Disease Protein MJD/ataxin-3
Q22 and Q62 refer to MJD protein-GFP fusions containing 22 and 62 Gln residues, respectively.
(A) Representative fluorescence micrographs illustrating the effect of glutamine repeat length and the [PIN] prion on MJD-GFP aggregation.
Q22 and Q62 were overexpressed in [psi] [pin] and [psi] [PIN] strains. Note the single large inclusion (top right) seen in a subset of [pin]
Q62 cells; in contrast, [PIN] Q62 cells displayed more abundant multiple aggregates (bottom right).
(B) Centrifugation analysis of MJD-GFP. Lysates prepared from the indicated strains overexpressing either Q22 or Q62 were subjected to
ultracentrifugation and the total (T), supernatant (S), and pellet (P) fractions were analyzed by SDS-PAGE followed by immunoblotting with
-GFP. Q22 is distributed equally between the supernatant and the pellet in both strains, while Q62 sediments almost entirely to the pellet
of the [PIN] extract but remains soluble in the [pin] extract. The smaller bands (GFP) likely result from proteolytic removal of the MJD region;
as expected, these fragments are not depleted from the supernatant.
(C) Effect of various yeast prions on Q62 aggregation. For each of the indicated strains, the fraction of cells with multiple fluorescent foci was
determined as in Figure 3A. The lower stimulation of aggregation of Q62 by [NU] compared to [PIN] may result from the rapid reversion of
these strains to [nu] under these conditions (data not shown). Note that [PSI] does not stimulate Q62 aggregation.
(D) Representative [nu] [pin] and [NU] [pin] cells overexpressing Q22 and Q62.
argue against this model. Sup35p prion propagation is As an alternative model, we suggest that there may
exist saturable cellular factors that antagonize de novotypically self-specific; even single amino acid changes
can prevent cross-seeding between wild-type and mu- formation of prion-like aggregates. In a prion-free ([psi]
[pin]) strain, overexpressed Sup35p could be recog-tant Sup35p proteins (DePace et al., 1998). While a small
portion of New1p does resemble an oligopeptide repeat nized by these antiaggregation factors and prevented from
aggregating. Aggregates of Rnq1p or New1p, whethersequence found in Sup35p, this region proved dispens-
able for [PSI] induction. Furthermore, New-GFP over- arising from overexpression or the presence of heritable
prions, could specifically inhibit this antiaggregation fac-expression alone failed to induce [PSI], and Sup35p
overexpression did not stimulate [NU] induction. Fi- tor, thereby allowing Sup35p to form the [PSI] prion.
Chaperones and proteases can inhibit protein aggre-nally, Sup-YFP and New-CFP aggregates in the same
cell did not colocalize. Despite these findings, it remains gation (Kopito, 2000), and are thus attractive candidates
for saturation by [PSI]-promoting factors. Although ov-possible that some cross-seeding could occur at a low
level, and we are unable to conclusively rule out such erexpression of several chaperones known to affect
[PSI] propagation did not appear to influence [PSI]a basis for the observed phenomena.
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induction, multiple chaperones may be simultaneously polyGln aggregates, which are not known to be prion-
like in character. A surprisingly large number of Gln/inhibited by [PSI]-promoting prions. For example, it
has been shown that Rnq1p aggregates interact with Asn-rich domains (1% of total genomic ORFS) are
encoded by eukaryotic genomes (Michelitsch andan Hsp40/Hsp70 protein pair (Sis1p and Ssa1p) (Sond-
heimer et al., 2001). Alternatively, degradation of aggre- Weissman, 2000). Given the tendency of proteins of this
type to aggregate, it is likely that cells seek to preventgation-prone proteins by cellular proteases could be
inhibited by prion-promoting aggregates; polyGln-rich such potentially deleterious misfolding. Differences in
the level of antiaggregation activity from one cell typeaggregates have in fact been recently found to saturate
the proteasome (Bence et al., 2001). Preliminary data to another could contribute to the tissue specificity of
polyGln diseases. Pathogenic aggregates may developsuggest that Sup-GFP is subject to amino-terminal pro-
teolytic processing, but overexpression of New-GFP or spontaneously in cells with a lower capacity to inhibit
the initiation of polyGln aggregates. Once established,the presence of [PIN] antagonizes this effect (L.Z.O.
and J.S.W., unpublished data). This inhibition of proteol- Gln/Asn-rich aggregates are likely to be difficult to elimi-
nate and could tax the cell’s ability to prevent otherysis occurs even with a mutant Sup-GFP (DePace et al.,
1998) that does not aggregate, arguing that this protec- proteins from aggregating. Further studies of the initia-
tion of aggregation in yeast and higher eukaryotes maytion from proteolysis is not merely a consequence of
Sup35p aggregation. thus prove fruitful in the identification of targets for pro-
phylaxis against aggregation-based neurodegenerativeOur findings also shed light on the role of Hsp104p
in the induction and maintenance of [PSI]. To explain diseases.
the dependence of [PSI] on Hsp104p, two models
Experimental Procedures(which are not mutually exclusive) have been proposed.
Hsp104p could assist the folding of Sup35p into an ag-
Yeast Strains and Methodsgregation-competent state required for [PSI] formation
Strains: [PSI] and ade1-14 were introduced into W303 yeast by
(Patino et al., 1996). Alternatively, the dissaggregation mating against the strain 74D-694a (Chernoff et al., 1995), followed
activity of Hsp104p may be needed to split up Sup35p by four backcrosses against the W303 parent, ultimately producing
aggregates to allow efficient distribution of the prion YJW 508 ( [PSI] [PIN] MAT, ade1-14, his3-11,15, leu2-3, trp1-1,
ura3-1). YJW 509, the [psi] [pin] derivative of this strain, wasto daughter cells in cell division (Kushnirov and Ter-
obtained by growth of YJW 508 on medium containing 5 mM guani-Avanesyan, 1998). Because deletion of HSP104 elimi-
dine hydrochloride (Tuite et al., 1981). A MATa [psi] [PIN] butnates all known yeast prions including [PIN], it has
otherwise isogenic strain (YJW 564) was obtained by transient over-
hitherto been impossible to determine whether Hsp104p expression of Hsp104p in a sister spore of YJW 508. The [PSI]
is needed for the formation of Sup35p prion aggregates. [pin] derivative (YJW 616) was obtained as described in Figure 1A.
However, overexpression of New1p circumvents the re- Unless otherwise noted, all yeast methods were as described in
(Sherman, 1991). Deletions of HSP104, NEW1, and RNQ1 were madequirement for [PIN] in [PSI] induction, allowing us to
using heterologous gene replacement (Longtine et al., 1998). SUP35test the effect of HSP104 deletion on de novo Sup35p
was disrupted by omega integration of a linear DNA fragment con-aggregation. We found that Sup-YFP in cells with aggre-
sisting of the TRP1 open reading frame flanked by the 500 base
gated New-CFP forms visible inclusions of similar ap- pairs on either side of SUP35.
pearance and frequency in both hsp104 and wild-type
strains, demonstrating that Hsp104p is not needed for Plasmid Construction
Sup35p aggregation per se. However, because Hsp104p High-copy yeast plasmids were derived from pRS424, pRS425, and
pRS426, while low-copy plasmids were derived from pRS314 andis required for propagation of [PSI], we were not able
pRS315 (Christianson et al., 1992). All yeast expression vectors usedto directly test whether these aggregates were prions.
a previously described modular system (Santoso et al., 2000) com-
posed of a promoter flanked by 5 XhoI and 3 BamHI/SalI sites, a
Implications for Human polyGln Gln/Asn-rich domain module flanked by 5 BamHI/SalI and 3 BlgII/
Protein Aggregation EcoRI sites, and in-frame GFP/CFP/YFP/EF modules flanked by 5
BglII/EcoRI and 3 SacI/NotI sites.A set of neurodegenerative diseases, including spino-
Sup35pCA-GFP, New-GFP, and New-EF constructs were de-cerebellar ataxia type 3/Machado-Joseph Disease (MJD)
scribed previously (Santoso et al., 2000); for two-color fluorescenceand Huntington’s Disease, result from the expansion of
experiments, the GFP modules of these constructs were replaced byglutamine repeats that cause the affected proteins to
the appropriate GFP variant (Clontech). Other Gln/Asn-rich domains
form intracellular inclusions. We have found that, in were amplified by PCR from yeast genomic DNA using oligonucleo-
yeast, the [PIN] and [NU] prions strongly modulate tides with 5 BamHI or SalI and 3 EcoRI linkers and cloned into the
above vectors.the aggregation of a fragment of the MJD protein bearing
Construction of polyGln-expanded MJD fragment: to avoid ge-pathogenic glutamine tracts. Recently, it was demon-
netic instability associated with pure CAG repeats, we designedstrated that deletion of HSP104 abolishes the aggrega-
complementary oligonucleotides encoding multiples of 20 glutaminetion of glutamine-expanded Huntington’s Disease pro-
residues using a mixture of CAG and CAA codons. These were
tein in a yeast model (Krobitsch and Lindquist, 2000). annealed and inserted into the KpnI and BamHI sites of a bacterial
Our results suggest that this requirement for HSP104 shuttle vector. Inserting additional such cassettes into the resulting
construct increased the polyGln tract in increments of 20. The po-may in part reflect the role of this chaperone in the
lyGln tracts were inserted after residue 14 of a truncated MJD frag-maintenance of [PIN] or possibly other unidentified pri-
ment (residues 203–284) (Ikeda et al., 1996), which was then intro-ons that promote polyGln aggregation.
duced into the GFP expression system described above.The stimulation of MJD protein aggregation by [PIN]
High copy expression plasmids bearing HSP104, SSA1, and SSB1
and [NU] establishes that the aggregation-promoting were constructed by amplification from genomic DNA of these
effect of these prions is not idiosyncratic to Sup35p ORFS, as well as 500 bp on either side, followed by cloning into
pRS423.but rather that they can also enhance the formation of
Prion-Based Regulation of Protein Aggregation
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